8 Matching Annotations
  1. Nov 2025
    1. Alterations of miRNA expression has been reported in studies on post-mortem brain tissue of schizophrenia patient, and upregulation of miR-328, miR-17-5p, miR-134, miR-652, miR-382, and miR-107 has been detected (Perkins et al., 2007; Santarelli et al., 2011). Analysis on brain tissue has further revealed that expression of miR-130b is located in the locus susceptible for schizophrenia (Burmistrova et al., 2007). I

      This section highlights how specific microRNAs such as show altered expression in the brains of schizophrenia patients. The mention of miR-130b being located within a schizophrenia susceptibility locus suggests possible genetic-epigenetic interplay.

    2. hypomethylations have also been detected in other genes, such as AluY A3 CpG (Li et al., 2019), promoter of GRIN2B (Fachim et al., 2019), CpG2 and CpG3 in TREM2 intron 1 (Yoshino et al., 2017), CpG sites in FAM63B and intergenic region on chromosome 16, CpG sites in TBC1D22A (Sugawara et al., 2018), and COMT (Nour El Huda et al., 2018) in schizophrenia compared with controls. Additionally, methylation of COMT was lower in atypical antipsychotics group compared to typical antipsychotics group

      This passage draws attention to how hypomethylation has been observed in multiple genes in schizophrenia patients, suggesting that widespread epigenetic alterations may influence diverse biological pathways involved in the disorder. Importantly the finding that COMT methylation is lower in patients with atypical antipsychotics.

    3. The non-coding RNAs (ncRNAs) are unique RNA transcripts that have been widely identified in eukaryotic genomes and play critical parts in the occurrence and development of many diseases.

      This is especially relevant for schizophrenia research, as ncRNAs including microRNAs and long non-coding RNAs—have emerged as important regulators of gene expression without coding for proteins. Their ability to fine-tune molecular pathways is increasingly being linked to psychiatric disorders.

    4. In contrast, DNA hypomethylation has also been identified in brain tissue and peripheral blood of schizophrenia patients. For instance, the hypomethylation of promoter region of catechol-O-methyltransferase (COMT), the gene from dopaminergic pathway, has been revealed in frontal lobe in schizophrenia (Abdolmaleky et al., 2006)

      This passage underscores the discovery that DNA hypomethylation—specifically in the promoter region of the COMT gene—has been observed in schizophrenia. COMT plays a critical role in dopamine metabolism, a pathway strongly linked to schizophrenia symptoms.

    5. Mental disorders are complex, multifactorial diseases involving chronic changes in the structure and function of neural circuits. Schizophrenia and several other mental disorders are highly hereditary (Burmeister et al., 2008), while epigenetic disorders are caused by environmental factors such as certain life experiences and stress.

      DNA methylation in regulatory regions, such as promoters, leads to the formation of 5-methylcytosine. This modification blocks transcription factor binding, meaning genes in these regions are less likely to be activated. Such changes can profoundly influence neural development

    6. If the DNA regulatory sequences contain a large amount of 5-methylcytosine, it can block the binding of transcription factors to DNA, thus affecting gene transcription.

      This highlights the fundamental mechanism by which DNA methylation can regulate gene expression. By increasing methylation of certain sequences, the DNA physically prevents transcription factors from binding to their target sites. This leads to transcriptional silencing.

    7. Both genetic and environmental factors are considered as important contributors to the development and progression of this disorder. The environmental factors have been linked to changes in gene expression through epigenetic modulations,

      This sets up the reason epigenetics matters in schizophrenia: not just genetic inheritance but modifiable environmental impacts shape risk and progression. Epigenetic mechanisms such as DNA methylation, ncRNA regulation, histone modification serve as bridges between what you inherit and what you experience.

    8. Some schizophrenia- and autism-associated genes, such as DLG4 (disks large homolog 4, MIM 602887), DRD2 (dopamine receptor D2, MIM 126450), NOS1 (nitric oxide synthase 1, MIM 163731), NRXN1 (neurexin-1, MIM 600565), and SOX10 (sex-determining region Y-box 10, MIM 602229), have all been shown to have age-related dynamically methylated changes throughout the entire lifetime, especially in the fetal and postnatal stages

      Key schizophrenia/autism genes with varying lifetime methylation patterns. Important for understanding neurodevelopment. This fits with article summary that epigenetic mechanism like methylation influence schizophrenia development. DLG4, DRD2, NOS1 and SOX10 are genes with varying methylations that influence schizophrenia.